Single Dose Preoperative Gabapentin Use in Minimally Invasive Hysterectomy for Acute Pain Management
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the investigators' study is to assess the efficacy of a single dose of
preoperative gabapentin within an enhanced recovery after surgery protocol in acute
postoperative pain reduction for women undergoing a minimally invasive hysterectomy.
Participants who consent to participate will be randomized to either a control group without
gabapentin or to a study arm and receive gabapentin 600 mg prior to their planned surgery.
The investigators will collect data on postoperative narcotic use, subjective pain as rated
by a numeric pain scale, in addition to any adverse effects of single dose gabapentin use.